These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23037800)

  • 1. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.
    Uno H; Tian L; Cai T; Kohane IS; Wei LJ
    Stat Med; 2013 Jun; 32(14):2430-42. PubMed ID: 23037800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement Screening for Ultra-High Dimensional Data with Censored Survival Outcomes and Varying Coefficients.
    Yue M; Li J
    Int J Biostat; 2017 May; 13(1):. PubMed ID: 28541925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphical procedures for evaluating overall and subject-specific incremental values from new predictors with censored event time data.
    Uno H; Cai T; Tian L; Wei LJ
    Biometrics; 2011 Dec; 67(4):1389-96. PubMed ID: 21504421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.
    Li J; Jiang B; Fine JP
    Biostatistics; 2013 Apr; 14(2):382-94. PubMed ID: 23197381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating incremental values from new predictors with net reclassification improvement in survival analysis.
    Zheng Y; Parast L; Cai T; Brown M
    Lifetime Data Anal; 2013 Jul; 19(3):350-70. PubMed ID: 23254468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting incremental value of markers added to risk prediction models.
    Pencina MJ; D'Agostino RB; Pencina KM; Janssens AC; Greenland P
    Am J Epidemiol; 2012 Sep; 176(6):473-81. PubMed ID: 22875755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landmark risk prediction of residual life for breast cancer survival.
    Parast L; Cai T
    Stat Med; 2013 Sep; 32(20):3459-71. PubMed ID: 23494768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of performance of survival prediction models for cancer prognosis.
    Chen HC; Kodell RL; Cheng KF; Chen JJ
    BMC Med Res Methodol; 2012 Jul; 12():102. PubMed ID: 22824262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can survival prediction be improved by merging gene expression data sets?
    Yasrebi H; Sperisen P; Praz V; Bucher P
    PLoS One; 2009 Oct; 4(10):e7431. PubMed ID: 19851466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bootstrap-based procedures for inference in nonparametric receiver-operating characteristic curve regression analysis.
    Rodríguez-Álvarez MX; Roca-Pardiñas J; Cadarso-Suárez C; Tahoces PG
    Stat Methods Med Res; 2018 Mar; 27(3):740-764. PubMed ID: 29233083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
    Pencina MJ; D'Agostino RB; D'Agostino RB; Vasan RS
    Stat Med; 2008 Jan; 27(2):157-72; discussion 207-12. PubMed ID: 17569110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent receiver operating characteristic curve estimator for correlated right-censored time-to-event data.
    Beyene KM; Chen DG
    Stat Methods Med Res; 2024 Jan; 33(1):162-181. PubMed ID: 38130110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
    Hayashi K; Eguchi S
    Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.
    Mihaescu R; van Zitteren M; van Hoek M; Sijbrands EJ; Uitterlinden AG; Witteman JC; Hofman A; Hunink MG; van Duijn CM; Janssens AC
    Am J Epidemiol; 2010 Aug; 172(3):353-61. PubMed ID: 20562194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.
    Cook NR; Ridker PM
    Ann Intern Med; 2009 Jun; 150(11):795-802. PubMed ID: 19487714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation-adjusted regression survival scores for high-dimensional variable selection.
    Welchowski T; Zuber V; Schmid M
    Stat Med; 2019 Jun; 38(13):2413-2427. PubMed ID: 30793795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate.
    Rodríguez-Álvarez MX; Meira-Machado L; Abu-Assi E; Raposeiras-Roubín S
    Stat Med; 2016 Mar; 35(7):1090-102. PubMed ID: 26487068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.
    Hu C; Steingrimsson JA
    J Biopharm Stat; 2018; 28(2):333-349. PubMed ID: 29048993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.